PreferredStockChannel
XOMA Corp | 8.375% Depositary Shares Series B Cumulative Perpetual Preferred Stock (XOMAO)

Prospectus excerpt:  XOMA Corporation is offering 1,400,000 depositary shares, each representing a 1/1000th fractional interest in a share of 8.375% Series B Cumulative Perpetual Preferred Stock (the “Series B Preferred Stock”), which we refer to in this prospectus as the depositary shares. 1,400 shares of Series B Preferred Stock underlying the depositary shares will be deposited with American Stock Transfer & Trust Company, LLC, as depositary. As a holder of the depositary shares, you will be entitled to all proportional rights, preferences and privileges of the Series B Preferred Stock represented thereby, including dividend, voting, redemption and liquidation rights and preferences. The proportionate liquidation preference of each depositary share is $25.00.

Full Prospectus PDF », Secondary Prospectus PDF », XOMA Page »

Series:B
Redeemable?:Yes
Call Date:4/15/2022 (Now Trading Post Call Date)
Perpetual?:Yes
Cumulative?:Yes
Shares Offered:1,400,000
Overallotment:200,000
Liquidation Preference:$25.00
Recent Market Price:$25.00
Premium to Liquidation Preference:
(More Preferreds Trading at a Premium »)
$0.00 (0.00%)
Annualized Dividend:2.09376
Recent Ex-Date:4/2/2024
Current Yield:8.38%
Original Coupon:8.375%
Pay Period:Quarterly
Pay Dates:15-Jan, 15-Apr, 15-Jul, 15-Oct
CDx3 Compliance Rating: Learn XOMAO's Rating
XOMA is a biotech royalty aggregator. Co. has a portfolio of economic rights to milestone and royalty payments associated with partnered pre-commercial therapeutic candidates. Co.'s portfolio was built through licensing its proprietary products and platforms from its discovery and development business, combined with acquisitions of rights to milestones and royalties.

Preferreds: XOMAP, XOMAO


Open the XOMA Information Page »
Name: 
XOMA Corp
Website: 
www.xoma.com
Sector: 
Drugs & Pharmaceuticals
Number of ETFs Holding XOMA: 
11 (see which ones)
Total Market Value Held by ETFs: 
$16,803,419
Total Market Capitalization: 
$297,000,000
% of Market Cap. Held by ETFs: 
5.66%

Quotes delayed 20 minutes

Email EnvelopeFree Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
Top Ten Highest Yielding Preferred Stocks
Feel-Good Income: Socially Responsible Preferreds
Dividend Channel's 25 S.A.F.E. Dividend Stocks
Increasing Payments For Decades

Safer than S.A.F.E: Preferreds of Dividend Channel's
S.A.F.E. Dividend Stocks

Recent Preferred Stock Offerings
Preferred Stocks of Dow Components
Preferred Stocks of S&P 500 Components
Preferred Stocks By Industry
Preferred Stocks Where Insiders Are Buying The Common
High Yield Preferred Stocks
Preferreds Trading At Premiums To Liquidation Preference
Preferreds Trading At Discounts To Liquidation Preference
The Top 10 DividendRank'ed U.S. Stocks
The Top 10 DividendRank'ed Canadian Stocks
Top 25 Broker Analyst Picks of the S&P 500
Stock market game

XOMA Corp | 8.375% Depositary Shares Series B Cumulative Perpetual Preferred Stock (XOMAO) Information Page | Preferred Stock Channel | www.PreferredStockChannel.com

Copyright © 2010 - 2024, All Rights Reserved Nothing in Preferred Stock Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact Preferred Stock Channel; Meet Our Editorial Staff.